SCHEMBL12907439

SCHEMBL12907439

Cc1n[nH]c2ccc(-c3ccc(O)cc3)cc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.59
MAP2K4 P45985 3/20 0.59
MAPKAPK2 P49137 3/20 0.59
MAPK6 Q16659 3/20 0.59
MAPKAPK3 Q16644 2/20 0.59
MAPKAPK5 Q8IW41 1/20 0.59
FGFR1 P11362 5/20 0.56
FGFR2 P21802 3/20 0.56
FGFR3 P22607 2/20 0.56
JAK2 O60674 5/20 0.54
MKNK1 Q9BUB5 1/20 0.51
PDPK1 O15530 2/20 0.49
HSP90AB1 P08238 1/20 0.49
PRKAG1 P54619 1/20 0.44
PRKAA1 Q13131 1/20 0.44
PRKAB1 Q9Y478 1/20 0.44
GSK3B P49841 1/20 0.44
CHEK1 O14757 1/20 0.43
DYRK1A Q13627 1/20 0.43
DYRK1B Q9Y463 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12907451 0.86 FGFR1 (0.70) MAPK1MAP2K4MAPKAPK2MAPK6MAPKAPK3
SCHEMBL19188029 0.86 JAK2 (0.57) MAPK1MAP2K4MAPKAPK2MAPK6MAPKAPK3
SCHEMBL23062796 0.85 MAP2K4 (0.53) MAPK1MAP2K4MAPKAPK2MAPK6MAPKAPK3
SCHEMBL12907433 0.85 MKNK1 (0.51) MAPK1MAP2K4MAPKAPK2MAPK6MAPKAPK3
SCHEMBL27968550 0.84 MKNK1 (0.71) MAP2K4JAK2MKNK1PRKAG1PRKAA1
SCHEMBL10213932 0.81 JAK2 (0.72) MAPK1MAP2K4MAPKAPK2MAPK6MAPKAPK3
SCHEMBL22513706 0.80 JAK2 (0.51) JAK2MKNK1PDPK1PRKAG1PRKAA1
SCHEMBL22339348 0.80 JAK2 (0.51) JAK2MKNK1PDPK1PRKAG1PRKAA1
SCHEMBL22513720 0.79 JAK2 (0.50) JAK2MKNK1PDPK1PRKAG1PRKAA1
SCHEMBL12907440 0.78 JAK2 (0.48) MAPK1MAP2K4MAPKAPK2MAPK6MAPKAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872039-B2 N-3-chlorobenzyl-3-amino-1H-indazole-5-carboxamide; 3-aminoindazoles; glucocorticoid-depedent kinase (SGK) inhibitors; SGK-induced diseases; diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, fibrosis; inflammatory agents MERCK PATENT GESELLSCHAFT (DE) 2011-01-18 US disclosed